Johnson & Johnson subsidiaries ordered to pay more than $81 million in Topamax case

Johnson & Johnson subsidiaries ordered to pay more than $81 million in Topamax case



AP FILE PHOTO A federal judge in Boston has ordered two subsidiaries of pharmaceutical giant Johnson & Johnson to pay more than $81 million after pleading guilty to illegally promoting the epilepsy drug Topamax for psychiatric uses. Ortho-McNeil Pharmaceutical LLC...

Read more on NJ.com

Love HuffPost? Become a founding member of HuffPost Plus today.

This article originally appeared on HuffPost.